Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Preventing myopia in children using distance-image screens

Official title: Clinically Study the Ocular Axial Length and Sphere Equivalence Changes of Children With Distance-image Screen Usage for One Year

Run by Beijing Airdoc Technology Co., Ltd. · NCT06088225 · Data updated 2026-11-12

This study is testing a special screen to see if it can help prevent nearsightedness in kids aged 6 to 12 by having them use it for at least 2 hours a day for a year.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment100 (estimated)
SponsorBeijing Airdoc Technology Co., Ltd.
Industry-sponsored
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedDecember 31, 2024
Study endsDecember 31, 2026
Registry record updatedOctober 24, 2023
Trial IDNCT06088225 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 6 to 12 years with specific refractive error criteria and no significant ocular diseases.

Probably not a fit

Patients with strabismus, amblyopia, cataracts, glaucoma, or other severe ocular conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the efficacy and safety of distance-image screens designed to prevent myopia in children aged 6 to 12 years. Over a 12-month period, 100 volunteers will use the distance-image screen for at least 2 hours daily, with their ocular parameters assessed before and after the intervention. The study aims to measure changes in ocular axial length and refractive error through paired t-tests to evaluate the effectiveness of this approach.

Why it matters

Potential benefit: If successful, this intervention could significantly reduce the incidence of myopia progression in children.

How similar studies have gone: While the approach of using distance-image screens is relatively novel, similar interventions targeting myopia prevention have shown promise in other studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (1) Must be 6\~12 years old;
* (2) Must be best corrected visual acuity \< logMAR: 0.1;
* (3) Spherical Equivalence (SE) must be -1.00\~ + 6.00 Diopter (D),
* (4) Spherical Equivalence (SE) must have changed \> 1.25 Diopter (D) in the recent 2 years;
* (5) Must be astigmatism \<1.75 Diopter (D);
* (6) Must be anisometropia \<1.75 Diopter(D).

Exclusion Criteria:

* (1) Strabismus disease;
* (2) Amblyopia disease;
* (3) Cataract disease;
* (4) Glaucoma disease;
* (5) Severe dry eye disease;
* (6) Cannot use distance-image screen for 12 month;
* (7) Other severe diseases that would effect the use of distance-image screen.

Where it's running

  • Airdoc MPC Opthalmology Clinics
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Evaluating Atropine for Delaying Myopia in Children

    This study is testing if a low-dose eye drop can help slow down worsening eyesight in children aged 3 to 12 who are becoming nearsighted.

    Recruiting Phase 3 Laboratorios Sophia S.A de C.V. · Mexico City · NCT06389110

  • Combining red light therapy and special glasses to control myopia in children

    This study is testing whether red light therapy or special glasses can help slow down worsening eyesight in children aged 6 to 13 who have myopia.

    Recruiting Beijing Airdoc Technology Co., Ltd. · Xuzhou, Jiangsu · NCT05756959

  • Comparing a new software for eye refraction with traditional methods

    This study is testing a new eye refraction software called Mobilerone to see if it gives accurate results for adults and older children with nearsightedness and astigmatism compared to traditional methods.

    Recruiting at 2 sites Beijing Airdoc Technology Co., Ltd. · Beijing, Beijing Municipality and 2 other locations · NCT06059521

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.